Collection

Pain in vulnerable groups

Submission status
Closed
Pain is “an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage or described in terms of such damage” (IASP, 2020). Estimates suggest that at least one-quarter of people experience long-term persistent pain - an often invisible and misunderstood source of disability that affects one's ability to live, function and work. Healthcare systems are not set up or resourced to deal with such a prevalently overwhelming condition, so therapeutic advances are urgently required.

Editors

  • Prof Bettina S. Husebø Prof Bettina S. Husebø , 

    Prof Bettina S. Husebø

    Prof. B.S. Husebø, MD, PhD, is a specialist in anesthesiology, intensive and palliative care, nursing home medicine, and a postgraduate at Harvard University. Husebø is the leader of the Centre for Elderly and Nursing Home Medicine and head of Innovation, University of Bergen. Her research is focused on method development and randomized controlled intervention trials, including nursing home patients with complex chronic conditions and home-dwelling people with dementia. The assessment and treatment of pain, neuropsychiatric and behavioral disturbances, medication reviews, and end-of-life care are key. Her recent work involves a transdisciplin

  • Prof Christina Liossi Prof Christina Liossi , 

    Prof Christina Liossi

    Prof Christina Liossi is a paediatric psychologist and one of the world experts in paediatric pain. She has worked as an academic and clinician in the UK and abroad and has cared for children with various chronic medical conditions including cancer, cystic fibrosis, chronic kidney disease, epidermolysis bullosa, and sickle cell disease. Christina has contributed to national and international evidence-based guidelines on acute and chronic paediatric pain, pain in epidermolysis bullosa and sedation in children. She is currently Chair of the NIHR Pain and Palliative Care Clinical Studies Group. Christina’s randomized controlled clinical trials h

  • Dr Emily Harrop Dr Emily Harrop , 

    Dr Emily Harrop

    mily has been a Consultant in Paediatric Palliative Care at Helen & Douglas House Hospices since 2010, and the Medical Director since 2019. She is also an Honorary Consultant at Oxford University Hospitals NHS Trust. She is active in research in the field of pain & symptom management and mentors postgraduate research students in the field of palliative medicine. Emily undertook her specialist palliative care training at Great Ormond Street Hospital (including a post graduate diploma in Palliative Medicine); before this she completed a PhD in Neuroscience (Infant Pain) as well as some postgraduate training in Paediatric Clinical Pharmacology.

  • Dr Line Iden Berge Dr Line Iden Berge  &

    Dr Line Iden Berge

    Line Iden Berge is cand.med (2006) and PhD in epidemiology (2014), both from UiB, and has a specialist degree in psychiatry (2017) after residency training in Helse-Bergen. In 2019 she started a 4 year 50% post-doc position at Centre for Elderly and Nursing Home Medicine (SEFAS) at Department of Global Hublic health and Primary Care, combined with 50% position as old age psychiatrist at NKS Olaviken. She works with the LIVE@Home.Path trial, a NFR funded mixed method randomized controlled trial of a municipal intervention to support home dwelling persons with dementia and their caregivers, main outcome resource utilization and caregiver burden

  • Dr Monica Patrascu Dr Monica Patrascu

    Dr Monica Patrascu

    Monica Patrascu received a PhD in Systems Engineering in 2012 and is specialized in intelligent systems. Currently, they are working on modeling complex biosystems, from cognitive decisional processes to agent-based models of misinformation spread. In particular, Monica works with unobtrusive wearable monitoring applied to neurodegenerative diseases, developing digital biomarkers for symptom tracking in real-world everyday life for persons Parkinson’s disease and developing digital phenotyping algorithms to recognize trajectories at the end of life, including pain detection, for persons with dementia.

Articles (12 in this collection)